(Q44815030)

English

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model

scientific article published in May 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

author name string

Takashi Saika

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Takefumi Satoh

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Nobuyuki Kusaka

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Shin Ebara

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vladimir B Mouraviev

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Terry L Timme

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Timothy C Thompson

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

317-324

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Tumor immunotherapy: inching toward the finish line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

In situ gene therapy for prostate cancer: immunomodulatory approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

21 January 2018

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700709

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700709

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44815030&oldid=2206939209"